JP2004525354A5 - - Google Patents

Download PDF

Info

Publication number
JP2004525354A5
JP2004525354A5 JP2002554713A JP2002554713A JP2004525354A5 JP 2004525354 A5 JP2004525354 A5 JP 2004525354A5 JP 2002554713 A JP2002554713 A JP 2002554713A JP 2002554713 A JP2002554713 A JP 2002554713A JP 2004525354 A5 JP2004525354 A5 JP 2004525354A5
Authority
JP
Japan
Prior art keywords
binding
cell
receptor
reversible
biotin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002554713A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004525354A (ja
JP4416400B2 (ja
Filing date
Publication date
Priority claimed from EP00128634A external-priority patent/EP1227321A1/en
Application filed filed Critical
Publication of JP2004525354A publication Critical patent/JP2004525354A/ja
Publication of JP2004525354A5 publication Critical patent/JP2004525354A5/ja
Application granted granted Critical
Publication of JP4416400B2 publication Critical patent/JP4416400B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2002554713A 2000-12-28 2001-12-28 抗原特異的ｔ−細胞の機能的精製のための可逆的ｍｈｃ多量体染色法 Expired - Lifetime JP4416400B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00128634A EP1227321A1 (en) 2000-12-28 2000-12-28 Reversible MHC multimer staining for functional purification of antigen-specific T cells
PCT/EP2001/015353 WO2002054065A2 (en) 2000-12-28 2001-12-28 Reversible mhc multimer staining for functional purification of antigen-specific t cells

Publications (3)

Publication Number Publication Date
JP2004525354A JP2004525354A (ja) 2004-08-19
JP2004525354A5 true JP2004525354A5 (enExample) 2008-12-18
JP4416400B2 JP4416400B2 (ja) 2010-02-17

Family

ID=8170850

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002554713A Expired - Lifetime JP4416400B2 (ja) 2000-12-28 2001-12-28 抗原特異的ｔ−細胞の機能的精製のための可逆的ｍｈｃ多量体染色法

Country Status (5)

Country Link
US (2) US7776562B2 (enExample)
EP (2) EP1227321A1 (enExample)
JP (1) JP4416400B2 (enExample)
CA (1) CA2467434C (enExample)
WO (1) WO2002054065A2 (enExample)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040067532A1 (en) 2002-08-12 2004-04-08 Genetastix Corporation High throughput generation and affinity maturation of humanized antibody
WO2007085266A1 (en) * 2006-01-30 2007-08-02 Dako Denmark A/S High-speed quantification of antigen specific t-cells in whole blood by flow cytometry
EP1878744A1 (en) * 2006-07-13 2008-01-16 Max-Delbrück-Centrum für Molekulare Medizin (MDC) Epitope-tag for surface-expressed T-cell receptor proteins, uses thereof and method of selecting host cells expressing them
WO2008140573A2 (en) 2006-11-15 2008-11-20 Invitrogen Dynal As Methods for reversibly binding a biotin compound to a support
EP2361930A3 (en) 2007-03-26 2011-10-26 Dako Denmark A/S Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases
EP2167537A2 (en) 2007-07-03 2010-03-31 Dako Denmark A/S Compiled methods for analysing and sorting samples
CA2697193C (en) 2007-09-14 2017-06-06 Adimab, Inc. Rationally designed, synthetic antibody libraries and uses therefor
US8877688B2 (en) 2007-09-14 2014-11-04 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
WO2009039854A2 (en) 2007-09-27 2009-04-02 Dako Denmark A/S Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics
US10968269B1 (en) 2008-02-28 2021-04-06 Agilent Technologies, Inc. MHC multimers in borrelia diagnostics and disease
WO2010009735A2 (en) 2008-07-23 2010-01-28 Dako Denmark A/S Combinatorial analysis and repair
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
US10369204B2 (en) 2008-10-02 2019-08-06 Dako Denmark A/S Molecular vaccines for infectious disease
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
EP2479268B1 (en) * 2009-09-17 2020-11-04 JSR Corporation Dissociation method and dissociation agent for avidin and biotinderivatives
EP3456847B1 (en) 2010-05-06 2024-12-25 Adaptive Biotechnologies Corporation Monitoring solid transplant rejection using clonotype profiles
CN103124740B (zh) * 2010-09-21 2015-09-02 美国卫生和人力服务部 抗-ssx-2t细胞受体和相关材料及使用方法
US10023657B2 (en) 2010-10-01 2018-07-17 Ludwig Institute For Cancer Research Ltd. Reversible protein multimers, methods for their production and use
US9023604B2 (en) * 2011-07-18 2015-05-05 Iba Gmbh Method of reversibly staining a target cell
WO2013056090A1 (en) * 2011-10-12 2013-04-18 University Of Connecticut Affinity-based materials for the non-destructive separation and recovery of cells
SG11201404991YA (en) 2012-02-23 2014-09-26 Stage Cell Therapeutics Gmbh Chromatographic isolation of cells and other complex biological materials
CN102662054B (zh) * 2012-05-10 2014-08-13 东南大学 一种同步检测特异性胸腺依赖性淋巴细胞数量和功能的方法
EP2920204B1 (en) 2012-11-16 2019-09-18 IBA GmbH Streptavidin muteins and methods of using them
HRP20201906T1 (hr) 2013-12-20 2021-04-02 Fred Hutchinson Cancer Research Center Označene kimerne efektorske molekule i njihovi receptori
BR112016016740B1 (pt) 2014-01-21 2024-02-20 Stemcell Technologies Inc Método de separação de entidades alvo de uma amostra que compreende entidades alvo e entidades não alvo
SG11201608557UA (en) 2014-04-16 2016-11-29 Juno Therapeutics Gmbh Methods, kits and apparatus for expanding a population of cells
US11400115B2 (en) 2014-04-23 2022-08-02 Juno Therapeutics, Inc. Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
WO2015166049A1 (en) 2014-04-30 2015-11-05 Iba Gmbh Method of isolating a target cell
EP3037820A1 (en) 2014-12-27 2016-06-29 Miltenyi Biotec GmbH Cell detection methods and reagents having a releasable labelling moiety
WO2016166568A1 (en) 2015-04-16 2016-10-20 Juno Therapeutics Gmbh Methods, kits and apparatus for expanding a population of cells
WO2016176652A2 (en) 2015-04-29 2016-11-03 Fred Hutchinson Cancer Research Center Modified stem cells and uses thereof
JP6657721B2 (ja) 2015-09-30 2020-03-04 ソニー株式会社 細胞の分析方法、細胞分析用チップ、細胞分析用試薬、細胞分析用キット及び細胞分析用装置
KR20180108567A (ko) 2015-10-22 2018-10-04 주노 테라퓨틱스 게엠베하 형질도입을 위한 방법, 키트, 제제 및 장치
MA45489A (fr) 2015-10-22 2018-08-29 Juno Therapeutics Gmbh Procédés de culture de cellules, kits et appareil associés
MA45488A (fr) * 2015-10-22 2018-08-29 Juno Therapeutics Gmbh Procédés, kits et appareil de culture de cellules
WO2017180420A1 (en) 2016-04-11 2017-10-19 Board Of Regents, The University Of Texas System Methods and compositions for detecting single t cell receptor affinity and sequence
CA3028265A1 (en) 2016-06-28 2018-01-04 Technische Universitaet Muenchen Combination of reversible and irreversible cell labeling for analyzing receptor-ligand koff rate
TW202332461A (zh) 2016-08-11 2023-08-16 荷蘭商凱特製藥歐洲公司 製造和使用可溶性主要組織相容性複合體（ｍｈｃ）分子類之方法
US10294454B2 (en) 2016-08-24 2019-05-21 General Electric Company Methods and kits for cell activation
EP3336545A1 (en) 2016-12-13 2018-06-20 Miltenyi Biotec GmbH Reversible labeling of antigens in biological specimens
EP3336546B1 (en) 2016-12-13 2020-07-01 Miltenyi Biotec B.V. & Co. KG Reversible cell labelling with conjugates having two releasable binding sites
US11517627B2 (en) 2017-01-20 2022-12-06 Juno Therapeutics Gmbh Cell surface conjugates and related cell compositions and methods
IL270142B2 (en) 2017-04-27 2025-05-01 Juno Therapeutics Gmbh Oligomeric particle reagents and methods of use thereof
MX2020000900A (es) 2017-07-29 2021-01-08 Juno Therapeutics Inc Reactivos para expandir celulas que expresan receptores recombinantes.
EP3489684B1 (en) 2017-11-27 2024-06-26 Miltenyi Biotec B.V. & Co. KG Method for photobleaching stained cells
SG11202005272SA (en) 2017-12-08 2020-07-29 Juno Therapeutics Inc Process for producing a composition of engineered t cells
CN109917120B (zh) * 2017-12-12 2022-10-28 清华大学 检测翻译后修饰蛋白质与其配体间相互作用的成套试剂
EP3833742A2 (en) 2018-08-09 2021-06-16 Juno Therapeutics, Inc. Processes for generating engineered cells and compositions thereof
US20210246189A1 (en) 2018-09-03 2021-08-12 Technische Universitaet Muenchen A double peptide tag combining reversibility and flexible functionalization
MA53612A (fr) 2018-09-11 2021-09-15 Juno Therapeutics Inc Procédés d'analyse par spectrométrie de masse de compositions cellulaires modifiées
CN113227358A (zh) 2018-10-31 2021-08-06 朱诺治疗学有限公司 选择并刺激细胞的方法及用于所述方法的设备
SG11202104183RA (en) 2018-11-06 2021-05-28 Juno Therapeutics Inc Process for producing genetically engineered t cells
US12258373B2 (en) 2018-12-17 2025-03-25 Immudex Aps Panel comprising Borrelia MHC multimers
BR112021019722A2 (pt) 2019-04-09 2021-12-14 Nurix Therapeutics Inc Compostos de piperidina 3-substituídos para inibição de cbl-b, e uso de inibidor de cbl-b em combinação com vacina contra câncer e/ou vírus oncolítico
US12436151B2 (en) 2019-04-12 2025-10-07 Miltenyi Biotec B.V. & Co. KG Conjugates having an enzymmatically releasable detection moiety and a barcode moiety
EP3969447A1 (en) 2019-05-17 2022-03-23 Nurix Therapeutics, Inc. Cyano cyclobutyl compounds for cbl-b inhibition and uses thereof
KR20220015452A (ko) 2019-05-28 2022-02-08 밀테니 비오텍 비.브이. & 씨오. 케이지 유전자 변형된 t 세포의 생성 방법
AU2020287882A1 (en) 2019-06-07 2022-01-20 Juno Therapeutics, Inc. Automated T cell culture
JP2022538174A (ja) 2019-06-26 2022-08-31 ニューリックス セラピューティクス，インコーポレイテッド Ｃｂｌ－ｂ阻害のための置換ベンジル－トリアゾール化合物、及びそのさらなる使用
JP7605824B2 (ja) 2019-07-30 2024-12-24 ニューリックス セラピューティクス，インコーポレイテッド Ｃｂｌ－ｂの阻害のための尿素、アミド、および置換されたヘテロアリール化合物
CN114600172A (zh) 2019-08-30 2022-06-07 朱诺治疗学股份有限公司 用于将细胞分类的机器学习方法
EP4028049A1 (en) 2019-09-11 2022-07-20 Miltenyi Biotec B.V. & Co. KG In vitro method for transduction of t cells in the presence of malignant cells
KR20220101641A (ko) 2019-10-30 2022-07-19 주노 테라퓨틱스 게엠베하 세포 선택 및/또는 자극 장치 및 사용 방법
EP4078178B1 (en) 2019-12-20 2024-10-23 Miltenyi Biotec B.V. & Co. KG Reversible cell detection via mhc with conjugates having an enzymatically cleavable detection moiety
KR20220146480A (ko) 2020-01-28 2022-11-01 주노 쎄러퓨티크스 인코퍼레이티드 Ｔ 세포 형질도입 방법
AU2021213439B2 (en) 2020-01-31 2023-01-05 Cell.Copedia GmbH Methods of isolating a biological entity
JP2023519098A (ja) 2020-02-12 2023-05-10 ジュノー セラピューティクス インコーポレイテッド Ｃｄ１９指向性キメラ抗原受容体ｔ細胞組成物ならびにその方法および使用
IL295381A (en) 2020-02-12 2022-10-01 Juno Therapeutics Inc bcma-directed chimeric t-cell antigen receptor compounds and methods and uses thereof
EP4150057A2 (en) 2020-05-13 2023-03-22 Juno Therapeutics, Inc. Process for producing donor-batched cells expressing a recombinant receptor
EP3916393B1 (en) 2020-05-27 2023-01-25 Miltenyi Biotec B.V. & Co. KG Method for detection of cells by repetitive staining and destaining
WO2022043023A1 (en) 2020-08-27 2022-03-03 Miltenyi Biotec B.V. & Co. KG Releasable reagents for cell separation
WO2022048780A1 (en) 2020-09-07 2022-03-10 Miltenyi Biotec B.V. & Co. KG Conjugates having an enzymatically releasable detection moiety and a barcode moiety
CN117916256A (zh) 2021-05-06 2024-04-19 朱诺治疗学有限公司 用于刺激和转导t细胞的方法
WO2023017115A1 (en) 2021-08-11 2023-02-16 Iba Lifesciences Gmbh Fractionation of cells based on a marker protein
EP4227423A1 (en) 2022-02-09 2023-08-16 Technische Universität München Means and methods for identifying high affinity t-cells
US20250297282A1 (en) 2022-05-05 2025-09-25 Juno Therapeutics Gmbh Viral-binding protein and related reagents, articles, and methods of use
WO2023230581A1 (en) 2022-05-25 2023-11-30 Celgene Corporation Methods of manufacturing t cell therapies
WO2024100604A1 (en) 2022-11-09 2024-05-16 Juno Therapeutics Gmbh Methods for manufacturing engineered immune cells
CN121100267A (zh) 2022-12-09 2025-12-09 朱诺治疗学股份有限公司 使用全息成像预测细胞表型的机器学习方法
EP4658675A1 (en) 2023-02-03 2025-12-10 C3S2 GmbH Methods for non-viral manufacturing of engineered immune cells
WO2024182516A1 (en) 2023-02-28 2024-09-06 Juno Therapeutics, Inc. Cell therapy for treating systemic autoimmune diseases
EP4484441A1 (en) 2023-06-26 2025-01-01 Eberhard-Karls-Universität Tübingen Mhc-class i derived polypeptide
WO2025083196A1 (en) 2023-10-18 2025-04-24 Tq Therapeutics Gmbh A method of manufacturing a cellular therapy product and respective kits and devices

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948590A (en) * 1987-06-09 1990-08-14 Yale University Avidin or streptavidin conjugated liposomes
DE4237113B4 (de) * 1992-11-03 2006-10-12 "Iba Gmbh" Peptide und deren Fusionsproteine, Expressionsvektor und Verfahren zur Herstellung eines Fusionsproteins
US5595881A (en) * 1994-08-09 1997-01-21 Anergen, Inc. Method for the detection of antigen presenting cells
AU5917796A (en) 1995-04-11 1997-04-09 Trustees Of Boston University Streptavidin mutants
EP0851768B1 (en) * 1995-09-01 2002-04-24 University of Washington Interactive molecular conjugates
DE19641876B4 (de) * 1996-10-10 2011-09-29 Iba Gmbh Streptavidinmuteine
US5985658A (en) * 1997-11-14 1999-11-16 Health Research Incorporated Calmodulin-based cell separation technique
FR2841905B1 (fr) 2002-07-05 2004-09-03 Centre Nat Rech Scient Fragments fab mutants de l'anticorps anti-cd4 chimere 13b8.2 et leurs applications

Similar Documents

Publication Publication Date Title
JP2004525354A5 (enExample)
US11761956B2 (en) Nanopore biosensors for detection of proteins and nucleic acids
JP2017513524A5 (enExample)
US20190383813A1 (en) Methods for detecting peptide/mhc/tcr binding
Mazumdar et al. Easy-to-use dipstick tests for detection of lead in paints using non-cross-linked gold nanoparticle–DNAzyme conjugates
Tamerler et al. Materials specificity and directed assembly of a gold‐binding peptide
CN103797028B (zh) 使靶细胞可逆染色的方法
CN106662584B (zh) 分离靶细胞的方法
Nagase et al. Thermally Modulated Retention of Lymphoctytes on Polymer‐Brush‐Grafted Glass Beads
CN107735686A (zh) 具有内部蛋白质衔接子的纳米孔
EP2725359B1 (en) Cell separation method using a release system for cell-antibody-substrate conjugates containing a polyethylene glycol spacer unit
WO2002083937A3 (en) Methods using o6-alkylguanine-dna alkyltransferases
CA2423979A1 (en) Method for quantifying phosphokinase activity on proteins
JP2017514481A5 (enExample)
CN116338174B (zh) 包括使用多核苷酸报道分子和跨膜孔的确定靶分析物的存在或不存在的方法
JP2006007204A5 (enExample)
Mooney et al. Use of phage display methods to identify heptapeptide sequences for use as affinity purification ‘tags’ with novel chelating ligands in immobilized metal ion affinity chromatography
CN101995463A (zh) 用于斑点金免疫渗滤法检测类风湿关节炎免疫抗体的组合物
CA2432995A1 (en) Immunogenic hla-a2 supermotif-restricted peptides
Moring et al. Target specific sample preparation from aqueous extracts with molecular imprinted polymers
Mann et al. Epitope-specific binder design by yeast surface display
EP3548621A1 (en) Methods and systems for identifying candidate nucleic acid agent
JP2015505675A (ja) 抗体ライブラリスクリーニングのための一般戦略
Kanwar Designed ankyrin repeat protein (DARPin) based platform to study biomolecular interactions and develop biosensors
EP1568770A3 (en) Pharmaceutical use of compounds which bind to a mammalian trace amine receptor